Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Revision: v3.3.2 is now displayed, replacing Revision: v3.3.1.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded the labels 'Last Update Posted (Estimated)' and 'Revision: v3.3.1', and removed 'Last Update Posted' and 'Revision: v3.2.0'; this is a minor UI/versioning update that does not modify the study data or participation details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoChange DetectedA new trial site was added: Tainan, Taiwan, 704, with a Last Update Posted entry on 2025-11-06. The prior listing for Tainan City, Taiwan, 704 was removed on 2025-10-28.SummaryDifference0.2%

- Check38 days agoChange DetectedRecent changes appear to be updates to study record dates (e.g., 2025-10-28, 2025-10-09, 2025-10) and do not alter core content such as design, eligibility, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange DetectedUpdated the site version from v3.0.2 to v3.2.0; this is a metadata/versioning change with no other content changes.SummaryDifference0.0%

- Check82 days agoChange DetectedUpdated version 3.0.2 metadata: new dates (2025-09-15, 2025-09-11, 2025-09), new location strings (México, Mexico, 03100 and 14080), and updated label (Last Update Posted (Estimated)); removed older dates and revision 3.0.1 and the Back to Top item.SummaryDifference0.5%

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.